Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Genomic Medicine, |
RCV001265178 | SCV001443207 | likely pathogenic | Retinitis pigmentosa 4 | 2020-09-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001345144 | SCV001539246 | uncertain significance | not provided | 2020-10-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RHO protein function. This variant has been observed in individual(s) with autosomal dominant retinitis pigmentosa (PMID: 30972525). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 95 of the RHO protein (p.Leu95Pro). The leucine residue is moderately conserved and there is a moderate physicochemical difference between leucine and proline. |
Institute of Human Genetics, |
RCV002287489 | SCV002577849 | likely pathogenic | Retinal degeneration | 2021-11-08 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2,PP3,PP4 |